A Study to Evaluate Dose Levels of Ad26.COV2.S Administered as a Two-dose Schedule in Healthy Adults

Clinical trial NCT04908722 · COMPLETED

Trial details

NCT number: NCT04908722
Sponsor: Janssen Vaccines & Prevention B.V.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

COVID-19 Prevention

Start date: 2021-06-18
Primary completion: 2023-07-10
Enrollment: 1609

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.